ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
674 DELAYED PSA RESPONSES IN PERSONALIZED PEPTIDE VACCINATION FOR CASTRATE-RESISTANT PROSTATE CANCER PATIENTS PHASE II STUDY
The Journal of Urology
◽
10.1016/j.juro.2012.02.756
◽
2012
◽
Vol 187
(4S)
◽
Author(s):
Masanori Noguchi
◽
Fukuko Moriya
◽
Shigetaka Suekane
◽
Kei Matsuoka
◽
Satoko Matsueda
◽
...
Keyword(s):
Prostate Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Peptide Vaccination
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Related Documents
Cited By
References
A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
Biomedicine & Pharmacotherapy
◽
10.1016/j.biopha.2021.112226
◽
2021
◽
Vol 143
◽
pp. 112226
Author(s):
Eric Zhuang
◽
Edward Uchio
◽
Michael Lilly
◽
Xiaolin Zi
◽
John P. Fruehauf
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate
Annals of Oncology
◽
10.1093/annonc/mdw674
◽
2017
◽
Vol 28
(3)
◽
pp. 668
◽
Cited By ~ 1
Author(s):
E.R. Kessler
◽
D. Gao
◽
T.W. Flaig
◽
K. Breaker
◽
M. Wold
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Abiraterone Acetate
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy
The Prostate
◽
10.1002/pros.21485
◽
2011
◽
Vol 72
(8)
◽
pp. 834-845
◽
Cited By ~ 32
Author(s):
Masanori Noguchi
◽
Fukuko Moriya
◽
Shigetaka Suekane
◽
Kei Matsuoka
◽
Gaku Arai
◽
...
Keyword(s):
Prostate Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Castration Resistant Prostate Cancer
◽
Peptide Vaccination
◽
Castration Resistant
Download Full-text
A randomized, double-blind, placebo-controlled phase II study of testosterone replacement in men with asymptomatic castrate-resistant prostate cancer (PC).
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps241
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS241-TPS241
Author(s):
R. Z. Szmulewitz
◽
E. M. Posadas
◽
B. Manchen
◽
W. M. Stadler
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Testosterone Replacement
◽
Double Blind
◽
Double Blind Placebo
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: A Phase II study
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2008.06.003
◽
2010
◽
Vol 28
(1)
◽
pp. 21-27
◽
Cited By ~ 24
Author(s):
Mohammad Reza Safarinejad
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Safety And Efficacy
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
The extended/phase II study of safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate resistant prostate cancer (mCRPC) who failed either abiraterone (Abi) or enzalutamide (Enza)
Annals of Oncology
◽
10.1093/annonc/mdz248.055
◽
2019
◽
Vol 30
◽
pp. v355
◽
Cited By ~ 1
Author(s):
N.J. Vogelzang
◽
N. Gabrail
◽
Z. Malik
◽
F. Volterra
◽
L.T. Nordquist
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Extended Phase
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC)
Investigational New Drugs
◽
10.1007/s10637-010-9455-x
◽
2010
◽
Vol 29
(6)
◽
pp. 1465-1474
◽
Cited By ~ 49
Author(s):
Michael R. Harrison
◽
Noah M. Hahn
◽
Roberto Pili
◽
William K. Oh
◽
Hans Hammers
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
7014 A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive Castrate Resistant Prostate Cancer (CRPC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71392-8
◽
2009
◽
Vol 7
(2)
◽
pp. 410
Author(s):
E.K. Beardsley
◽
S.J. Hotte
◽
S. Ellard
◽
E. Winquist
◽
S. North
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Overall survival (OS) analysis of a phase II study using a pox viral-based vaccine, PSA-TRICOM, in the treatment of metastatic, castrate-resistant prostate cancer (mCRPC): Implications for clinical trial design
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.3005
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 3005-3005
◽
Cited By ~ 4
Author(s):
R. A. Madan
◽
J. L. Gulley
◽
W. L. Dahut
◽
K. Y. Tsang
◽
S. M. Steinberg
◽
...
Keyword(s):
Prostate Cancer
◽
Clinical Trial
◽
Overall Survival
◽
Phase Ii
◽
Trial Design
◽
Phase Ii Study
◽
Clinical Trial Design
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
126 Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naïve patients with metastatic castrate-resistant prostate cancer
European Urology Supplements
◽
10.1016/s1569-9056(12)60125-0
◽
2012
◽
Vol 11
(1)
◽
pp. e126-e126a
Author(s):
A.J. Armstrong
◽
J.R. Gingrich
◽
M Häggman
◽
W.M. Stadler
◽
J.E. Damber
◽
...
Keyword(s):
Prostate Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Safety And Efficacy
◽
Castrate Resistant Prostate Cancer
◽
Castrate Resistant
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close